Assessing Shifts in Research Priority Areas From the Neurological Community Before and After the COVID-19 Pandemic.

Publication date: Jun 01, 2026

People living with a neurological condition face many difficulties in daily life, impacting their function and quality of life (QoL). There is currently no cure to many neurological conditions, therefore identifying interventions to improve QoL is of high importance. COVID-19 changed society in many ways and understanding the research priorities from the neurological community post pandemic is urgently needed to ensure resources are used efficiently and aligned with the needs and priorities of the community. To better understand the priority areas, it is essential for individuals with lived experience to have input into priority areas for research. Therefore, the aim of this study was to identify the top research priorities for the neurological community in Australia. This priority setting study had two phases. The first phase comprised a face-to-face full day workshop held in late 2019 where participants were led through rounds of brainstorming, categorising and prioritising to reach consensus on a set of research priorities. The second phase was conducted in 2023 with an online survey distributed widely to gauge whether the initial set of research priorities had changed following the event of the global pandemic. On completion of the 2019 workshop there were a total of 27 priority areas with the top priority being diagnosis and early intervention. The 2023 survey results saw mental health and wellbeing moving up one position to become the highest priority. Mental health and wellbeing moving from second in 2019 to first in 2023, shows a need for more resources and research into this area for the neurological community. Many participants suggested that mental health is at the centre of their condition and when their mental health is poor it impacts all areas of their life. The research priorities identified in this study provide direction for researchers about what is important to people living with a range of neurological conditions, allowing researchers to focus on the needs of this community. The data collection phase was planned in collaboration with the Consumer and Community Health Research Network, a consumer advocacy organisation. We partnered with people living with neurological conditions for the data collection for both phases and they gave feedback on the findings.

Open Access PDF

Concepts Keywords
Australia consumers
Brainstorming neurological conditions
Covid qualitative
Pandemic research priorities

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH face
drug DRUGBANK Tropicamide
pathway REACTOME Translation
pathway REACTOME Reproduction
disease MESH multiple sclerosis
disease MESH stroke
disease MESH migraine
disease MESH neurological disorders
disease MESH tar
disease MESH dis
disease MESH anxiety
disease MESH chronic fatigue syndrome
disease MESH asthma
pathway KEGG Asthma
disease MESH Mul
disease MESH Sclerosis
disease MESH included
drug DRUGBANK Etoperidone
disease MESH pain
disease MESH fatigue
disease MESH Trauma
drug DRUGBANK Isoxaflutole
disease MESH Idiopathic intracranial hypertension
disease MESH plan
drug DRUGBANK Trestolone
disease MESH mental illness
disease MESH CBT
disease MESH Chronic Illness
drug DRUGBANK Phenylpropanolamine
disease MESH PPA
disease MESH Rare Diseases
disease MESH Parkinson’s Disease
disease MESH Lord
disease MESH Hemorrhagic Stroke
disease MESH Cerebrovascular Diseases
pathway KEGG Parkinson disease
disease MESH Affective Disorders
disease MESH Shock

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *